Viewing Study NCT05841550


Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-01-25 @ 9:26 AM
Study NCT ID: NCT05841550
Status: RECRUITING
Last Update Posted: 2025-08-05
First Post: 2023-03-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma
Sponsor: Oslo University Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-05-19
Start Date Type: ACTUAL
Primary Completion Date: 2027-05-19
Primary Completion Date Type: ESTIMATED
Completion Date: 2035-05-19
Completion Date Type: ESTIMATED
First Submit Date: 2023-03-13
First Submit QC Date: None
Study First Post Date: 2023-05-03
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-07-31
Last Update Post Date: 2025-08-05
Last Update Post Date Type: ACTUAL